Qingquan Li

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma.

P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma.

Journal: Redox biology

Published: May 25, 2026

Entinostat and Tucidinostat Potentiate Temozolomide Response in Glioblastoma Models.

Entinostat and Tucidinostat Potentiate Temozolomide Response in Glioblastoma Models.

Journal: Die Pharmazie

Published: March 06, 2026

Therapeutic effects of three-strain probiotic combination on slow transit constipation: mechanistic insights into MAPK signaling pathway and gut microbiota restoration.

Therapeutic effects of three-strain probiotic combination on slow transit constipation: mechanistic insights into MAPK signaling pathway and gut microbiota restoration.

Journal: Frontiers in pharmacology

Published: August 14, 2025

HOXC4 promotes proliferation of endometriotic stromal cells via the SLIT2-ROBO1 axis.

HOXC4 promotes proliferation of endometriotic stromal cells via the SLIT2-ROBO1 axis.

Journal: Molecular human reproduction

Published: January 12, 2025

Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib.

Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib.

Journal: Journal of translational medicine

Published: December 10, 2024

Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma.

Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma.

Journal: Cell metabolism

Published: June 29, 2023

YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.

YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.

Journal: Nature communications

Published: June 13, 2023

Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer.

Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer.

Journal: Bioorganic chemistry

Published: April 20, 2023

Hydroxyphenylpyruvate Dioxygenase Is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer.

Hydroxyphenylpyruvate Dioxygenase Is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer.

Journal: Gastroenterology

Published: August 05, 2022

Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas.

Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas.

Journal: Translational oncology

Published: June 09, 2022

Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors.

Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors.

Journal: Science translational medicine

Published: September 29, 2021

Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.

Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.

Journal: IUBMB life

Published: July 17, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026